The intensification of upstream bioprocessing sounds daring, as though it were equivalent to flooring a car’s accelerator pedal and pushing the tachometer into the red zone. But with the right ...

HCPs are unwanted impurities requiring removal during manufacturing, but new trehalose technology significantly reduces HCPs ...

The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this goal requires improved operational control and continuous real-time ...